{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:32Z","timestamp":1786984232330,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:00:00Z","timestamp":1429660800000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ajur.2015.04.019","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T15:08:48Z","timestamp":1429196928000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["All about Peyronie's disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Ahmed A.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Alwaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom F.","family":"Lue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2015.04.019_bib1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1743-6109.2007.00614.x","article-title":"Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib3","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1743-6109.2008.00949.x","article-title":"Risk factors for emotional and relationship problems in Peyronie's disease","volume":"5","author":"Smith","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ijcp.12129","article-title":"Understanding the course of Peyronie's disease","volume":"67","author":"Garaffa","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajur.2015.04.019_bib5","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.ijir.3900635","article-title":"Peyronie's disease in men under age 40: characteristics and outcome","volume":"13","author":"Tefekli","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1743-6109.2011.02502.x","article-title":"Peyronie's disease in teenagers","volume":"9","author":"Tal","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie's disease following radical prostatectomy: incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib10","series-title":"Guidelines on penile curvature","author":"European Association of Urology","year":"2014"},{"key":"10.1016\/j.ajur.2015.04.019_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1743-6109.2009.01584.x","article-title":"A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease","volume":"7","author":"Rhoden","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/01.ju.0000170231.51306.32","article-title":"Peyronie's disease in diabetic patients being screened for erectile dysfunction","volume":"174","author":"El-Sakka","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib14","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie's disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib15","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","article-title":"Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib17","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: trauma as the cause of the Peyronie's lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(01)65358-8","article-title":"International conference on Peyronie's disease advances in basic and clinical research. March 17\u201319, 1993. Introduction","volume":"157","author":"Devine","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.ijir.3900873","article-title":"Gene expression in Peyronie's disease","volume":"14","author":"Gonzalez-Cadavid","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11934-004-0074-y","article-title":"New discoveries in the basic science understanding of Peyronie's disease","volume":"5","author":"Jalkut","year":"2004","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ajur.2015.04.019_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2605.2007.00780.x","article-title":"Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease","volume":"31","author":"Piao","year":"2008","journal-title":"Int J Androl"},{"key":"10.1016\/j.ajur.2015.04.019_bib24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1743-6109.2009.01216.x","article-title":"IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease","volume":"6","author":"Ryu","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib25","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ijir.2011.18","article-title":"The association between Peyronie's and Dupuytren's disease","volume":"23","author":"Nugteren","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.12346","article-title":"Deformity stabilization and improvement in men with untreated Peyronie's disease","volume":"113","author":"Berookhim","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1095\/biolreprod.105.041038","article-title":"Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease","volume":"73","author":"Vernet","year":"2005","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajur.2015.04.019_bib29","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/jsm.12334","article-title":"Peyronie's disease plaque calcification\u2013prevalence, time to identification, and development of a new grading classification","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.juro.2009.12.026","article-title":"Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?","volume":"183","author":"Breyer","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2007.07.013","article-title":"The natural history of Peyronie's disease: an ultrasonography-based study","volume":"53","author":"Bekos","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ucl.2011.02.006","article-title":"Peyronie's disease: review of nonsurgical treatment options","volume":"38","author":"Larsen","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ajur.2015.04.019_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1464-410X.2011.10851.x","article-title":"Penile Doppler sonographic and clinical characteristics in Peyronie's disease and\/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction","volume":"110","author":"Chung","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2015.04.019_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.ijir.3900569","article-title":"Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease","volume":"12","author":"Kadioglu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)35997-9","article-title":"Penile vascular evaluation of men with Peyronie's disease","volume":"149","author":"Lopez","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1743-6109.2009.01623.x","article-title":"Standards for clinical trials in male sexual dysfunctions","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajur.2015.04.019_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2340\/00015555721518","article-title":"A comparison of morphoea and lichen sclerosus et atrophicus in\u00a0vitro: the effects of para-aminobenzoate on skin fibroblasts","volume":"72","author":"Griffiths","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajur.2015.04.019_bib40","first-page":"61","article-title":"A multicentre double-blind controlled clinical trial of potassium para-amino-benzoate (POTABA1) in Peyronie's disease","volume":"1","author":"Shah","year":"1983","journal-title":"Progr Reprod Biol Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Peyronie's Disease Study Group of Andrological Group of German U. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study","volume":"47","author":"Weidner","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib42","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","article-title":"Tamoxifen versus placebo in the treatment of Peyronie's disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie's disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2015.04.019_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ijir.3900519","article-title":"Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome","volume":"12","author":"Kadioglu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","article-title":"Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease","volume":"91","author":"Prieto Castro","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib46","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1006\/jmcc.1999.0968","article-title":"Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes","volume":"31","author":"Netticadan","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajur.2015.04.019_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1464-410x.2001.02241.x","article-title":"Acetyl-l-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report","volume":"88","author":"Biagiotti","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib48","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1743-6109.2010.01749.x","article-title":"Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: Interference in a TGF-beta1\/Smad-dependent mechanism and downregulation of AAT1","volume":"7","author":"Lin","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/aja.2010.117","article-title":"Pentoxifylline treatment and penile calcifications in men with Peyronie's disease","volume":"13","author":"Smith","year":"2011","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ajur.2015.04.019_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/j.1875-9114.1984.tb03380.x","article-title":"Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects","volume":"4","author":"Aviado","year":"1984","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajur.2015.04.019_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","article-title":"Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease","volume":"97","author":"Ferrini","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.ajur.2015.04.019_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ijir.2010.20","article-title":"Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study","volume":"22","author":"Safarinejad","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib54","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1743-6109.2009.01235.x","article-title":"Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: a prospective, randomized, double-blind placebo-controlled study","volume":"6","author":"Safarinejad","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study","volume":"5","author":"Jordan","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2164\/jandrol.108.006221","article-title":"Medical management of Peyronie's disease","volume":"30","author":"Hellstrom","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.ajur.2015.04.019_bib57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","article-title":"Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-5347(17)62993-8","article-title":"Steroid injection therapy for Peyronie's disease: a 10-year summary and review of 38 cases","volume":"97","author":"Desanctis","year":"1967","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib59","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2015.04.019_bib61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","article-title":"Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma","volume":"25","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.ajur.2015.04.019_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1743-6109.2005.00110.x","article-title":"The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease","volume":"2","author":"Kendirci","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1743-6109.2006.00417.x","article-title":"Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease \u2013 a placebo-controlled pilot study","volume":"4","author":"Fitch","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1464-410X.2003.04242.x","article-title":"Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease","volume":"91","author":"Di Stasi","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib67","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","article-title":"Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial","volume":"177","author":"Greenfield","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib68","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1464-410X.2000.00827.x","article-title":"Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience","volume":"86","author":"Husain","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib70","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1464-410X.2010.09331.x","article-title":"Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial","volume":"106","author":"Chitale","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib71","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0266-7681(94)90220-8","article-title":"The continuous elongation technique for severe Dupuytren's disease. A biochemical mechanism","volume":"19","author":"Bailey","year":"1994","journal-title":"J Hand Surg Br"},{"key":"10.1016\/j.ajur.2015.04.019_bib72","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","article-title":"Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study","volume":"5","author":"Levine","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib73","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease","volume":"106","author":"Raheem","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2015.04.019_bib74","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042307-200411000-00015","article-title":"Critical analysis of surgery for Peyronie's disease","volume":"14","author":"Kendirci","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ijir.2011.6","article-title":"Should assessment of penetrative sexual activity be used as the treatment arbiter in the management of Peyronie's disease?","volume":"23","author":"Dukic","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ucl.2011.03.001","article-title":"Peyronie disease: plication or grafting","volume":"38","author":"Langston","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ajur.2015.04.019_bib77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib78","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-5347(17)63751-0","article-title":"Congenital curvature of the phallus: report of three cases with description of corrective operation","volume":"93","author":"Nesbit","year":"1965","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0022-5347(17)56530-1","article-title":"A new approach to the correction of the penile deformity in Peyronie's disease","volume":"122","author":"Pryor","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.ijir.3900331","article-title":"Correction of penile curvature and Peyronie's disease: why I prefer the Nesbit technique","volume":"10","author":"Pryor","year":"1998","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib81","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(01)66862-9","article-title":"The Nesbit operation for Peyronie's disease: 16-year experience","volume":"154","author":"Ralph","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ijir.3900612","article-title":"Long-term results with Nesbit's procedure as treatment of Peyronie's disease","volume":"12","author":"Savoca","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ajur.2015.04.019_bib83","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0022-5347(01)64953-X","article-title":"Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication)","volume":"157","author":"Rehman","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-5347(17)37941-7","article-title":"Venogenic impotence following dermal graft repair for Peyronie's disease","volume":"146","author":"Dalkin","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2006.04.030","article-title":"Surgical treatment of Peyronie's disease: a critical analysis","volume":"50","author":"Kadioglu","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-5347(17)55682-7","article-title":"Peyronie's disease: excision and autografting with tunica vaginalis","volume":"124","author":"Das","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-5347(05)66106-X","article-title":"A comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie's disease","volume":"166","author":"Chun","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib88","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11934-009-0073-0","article-title":"Peyronie's surgery: graft choices and outcomes","volume":"10","author":"Lentz","year":"2009","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ajur.2015.04.019_bib89","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0090-4295(00)01079-7","article-title":"Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease","volume":"57","author":"Knoll","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2015.04.019_bib90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1743-6109.2007.00407.x","article-title":"Surgical techniques: modeling technique for penile curvature","volume":"4","author":"Wilson","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.ajur.2015.04.019_bib91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nrurol.2012.221","article-title":"Sexual dysfunction: the potential of stem cell therapy for Peyronie disease","volume":"10","author":"Shindel","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajur.2015.04.019_bib92","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1089\/scd.2012.0176","article-title":"Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants","volume":"21","author":"Lin","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.ajur.2015.04.019_bib93","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.ajur.2015.04.019_bib94","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbrc.2010.10.090","article-title":"Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties","volume":"402","author":"Zhang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajur.2015.04.019_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","article-title":"Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease","volume":"63","author":"Castiglione","year":"2013","journal-title":"Eur Urol"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388215000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388215000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:29:10Z","timestamp":1762000150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388215000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2214388215000430"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2015.04.019","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All about Peyronie's disease","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2015.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}